Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Sample Collection for Quality Testing in Transdermal Patches

Posted on By

SOP for Sample Collection for Quality Testing in Transdermal Patches

Standard Operating Procedure for Sample Collection for Quality Testing in Transdermal Patches

1) Purpose

The purpose of this SOP is to establish procedures for the collection of samples from transdermal patch batches for quality testing to ensure compliance with specifications and regulatory standards.

2) Scope

This SOP applies to sample collection activities conducted during the manufacturing, packaging, and quality control of transdermal patches within the facility.

3) Responsibilities

The Production and Quality Control (QC) Departments are responsible for executing sample collection activities as per this SOP. Quality Assurance (QA) personnel provide oversight to ensure adherence to procedures and regulatory requirements.

See also  SOP for Endotoxin Testing in Aseptic Transdermal Patches

4) Procedure

4.1 Sampling Plan Development

  • 4.1.1 Develop a sampling plan specifying the number of samples, sampling points, and sampling frequency based on batch size and critical process parameters.
  • 4.1.2 Ensure sampling plan complies with regulatory guidelines and internal quality standards.

4.2 Sample Collection Process

  • 4.2.1 Collect samples at defined stages of production, including raw materials, in-process, and finished product stages, as per the sampling plan.
  • 4.2.2 Use validated sampling tools and techniques to ensure representative samples are obtained without contamination or degradation.

4.3 Sample Handling and Identification

  • 4.3.1 Label each sample container with unique identifiers, including batch number, sampling location, date, and initials of the sampler.
  • 4.3.2 Ensure proper storage and transportation conditions to maintain sample integrity until testing.
See also  SOP for Quality Control Testing of Transdermal Patches

4.4 Documentation and Recordkeeping

  • 4.4.1 Document all sample collection activities in batch records or sampling logs, including details of sample collection points, quantities, and any observations.
  • 4.4.2 Maintain traceable records of sample handling, storage conditions, and chain of custody throughout the testing process.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QC: Quality Control
QA: Quality Assurance

6) Documents, if any

Sampling Plan
Sample Collection Logs
Batch Records

7) Reference, if any

ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
USP General Chapters on Sampling

8) SOP Version

Version 1.0

Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

Post navigation

Previous Post: SOP for Analytical Method Development for Transdermal Patches
Next Post: SOP for Packaging Line Qualification for Aerosols

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version